FAM171A2 and female reproductive organ cancer: Further functional validation through cell-based and animal models will be critical to elucidate its mechanistic role and assess whether FAM171A2 or its regulatory RNA network can serve as a novel biomarker or therapeutic target in gynecologic cancers.